Korean Manufacturer Warned for Adulterated Products

Drug Industry Daily
A A
The FDA issued a warning letter to Korean drug manufacturer Amaros, citing significant quality and GMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily